Clinical Trials

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

51 enrolled

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

DermatologicHead & NeckLymphoidSarcoma

15 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT04634227 2026-05-22

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Sarcoma

Bone Neoplasms, Sarcoma

NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

NCT04219904 2026-05-20

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

25 enrolled

Uterine Cervical Neoplasms

NCT05495464 2026-05-20

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

22 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT06959563 2026-05-20

9vHPV-BCG

Papillomavirus Infections

NCT05056896 2026-05-15

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

161 enrolled 9 charts

Colorectal Neoplasms

NCT07585851 2026-05-14

Administration of Repurposed Ketoconazole in Glioma Patients

80 enrolled

CNSLymphoid

Glioblastoma, Lymphoma, Follicular

NCT04494113 2026-05-13

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

12 enrolled

Endometrial Serous Adenocarcinoma

NCT04161248 2026-05-12

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

40 enrolled

Lymphoid

Lymphoma, B-Cell

NCT06318871 2026-05-11

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

5 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT03143270 2026-05-07

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Liver Neoplasms

NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

EndocrineNET

Neuroendocrine Tumors

NCT04848961 2026-05-06

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Smoking

NCT05851365 2026-05-04

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

1 enrolled

Prostatic Neoplasms

NCT03541720 2026-04-29

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

13 enrolled

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT06228404 2026-04-28

Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC

18 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00737399 2026-04-27

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

14 enrolled

Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders, Neoplasms, Pain, Cholangiocarcinoma

NCT05816785 2026-04-22

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

15 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03163368 2026-04-17

Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

25 enrolled

Brain Neoplasms, Neoplasm Metastasis

NCT04134325 2026-04-17

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Lymphoid

Hodgkin Disease

NCT04656535 2026-04-17

AB154 Combined With AB122 for Recurrent Glioblastoma

46 enrolled

Glioblastoma, Recurrence

NCT02659241 2026-04-15

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

38 enrolled

Carcinoma, Fallopian Tube Neoplasms

NCT02790853 2026-04-15

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

63 enrolled

Mouth Diseases, Mouth Neoplasms

NCT03059940 2026-04-15

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

630 enrolled

Smoking Cessation

NCT05047913 2026-04-15

Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR

CNSGynecologic

Brain Neoplasms, Uterine Cervical Neoplasms

NCT05047965 2026-04-15

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

65 enrolled

Prostatic Neoplasms

NCT05053750 2026-04-15

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

14 enrolled

Epithelial Ovarian

NCT05108428 2026-04-01

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Colonic Neoplasms, Rectal Neoplasms

NCT04040088 2026-03-31

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT06789081 2026-03-23

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

1 enrolled

Sarcoma

Sarcoma, Alveolar Soft Part

NCT05477823 2026-03-20

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Prostatic Neoplasms

NCT04862260 2026-03-19

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

3 enrolled

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

2 enrolled

Colonic Neoplasms

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

42 enrolled

Glioblastoma, Glioma

NCT05182905 2026-03-09

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

97 enrolled

Glioblastoma, Glioma

NCT02933736 2026-03-06

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

48 enrolled

Glioblastoma, Meningioma

NCT02812420 2026-03-05

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

54 enrolled

Hydronephrosis, Ureteral Neoplasms, Urethral Neoplasms

NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

80 enrolled

Pelvic Mass

NCT03832569 2026-03-05

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

17 enrolled

Pathologic Complete Response

NCT05035706 2026-03-05

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

BreastGastrointestinalThoracic

27 enrolled

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07435415 2026-02-27

Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

Head and Neck Neoplasms

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

15 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03334500 2026-02-20

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

Prostatic Neoplasms

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors